CEOLIVE: Access Pharmaceuticals CEO - Jeff Davis

Interview with Mr. Jeffrey Davis, President & CEO of Access Pharmaceuticals, Inc. (OTCBB:ACCP).About Access: ;Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients. Access' products include MuGard™ (www.mugard.com), for the management of patients with mucositis, ProLindac™, currently in Phase II clinical testing of patients with ovarian cancer, and Thiarabine, a new generation nucleoside analog which has demonstrated both pre-clinical and clinical activity in certain cancers. The company also has additional advanced drug-delivery technologies, including CobaCyte™-mediated targeted delivery and CobOral-oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism. For additional information on Access Pharmaceuticals, please visit our website at

Category:

News & Politics

Tags:

• drug delivery technology
• oral drug delivery
• otc bulletin board